back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2025-12-16 13:35 Tx date 2025-12-16 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,270
+3,000 vol $1.09 each |
480,113 | |
| Filed 2025-12-15 16:48 Tx date 2025-12-15 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$94,817
+85,000 vol $1.12 each |
477,113 | |
| Filed 2025-12-15 14:00 Tx date 2025-12-15 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$35,520
+32,000 vol $1.11 each |
78,000 | |
| Filed 2025-12-15 12:21 Tx date 2025-12-12 |
$MDNA
Medicenna Therapeutics Corp. |
Hyman, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,200
+10,000 vol $1.12 each |
50,000 | |
| Older filings | ||||||
| Filed 2025-12-12 14:17 Tx date 2025-12-12 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,800
+15,000 vol $1.12 each |
46,000 | |
| Filed 2025-11-19 13:54 Tx date 2025-11-18 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+350,000 vol |
2,980,786 | |
| Filed 2025-09-30 17:22 Tx date 2025-09-25 |
$MDNA
Medicenna Therapeutics Corp. |
Hyman, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
600,000 | |
| Filed 2025-09-30 08:20 Tx date 2025-09-25 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
1,812,069 | |
| Filed 2025-09-30 08:19 Tx date 2025-09-25 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+350,000 vol |
2,630,786 | |
| Filed 2025-09-30 08:08 Tx date 2025-09-25 |
$MDNA
Medicenna Therapeutics Corp. |
Lalji, Karim Fatehali
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
200,000 | |
| Filed 2025-09-26 14:01 Tx date 2025-09-25 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
||
| Filed 2025-09-26 13:58 Tx date 2025-09-25 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+350,000 vol |
||
| Filed 2025-09-26 14:01 Tx date 2025-09-25 |
$MDNA
Medicenna Therapeutics Corp. |
MERCHANT, Rosemina
3 - 10% Security Holder of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
1,812,069 | |
| Filed 2025-09-26 13:58 Tx date 2025-09-25 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+350,000 vol |
2,630,786 | |
| Filed 2025-09-26 13:54 Tx date 2025-09-25 |
$MDNA
Medicenna Therapeutics Corp. |
Dawes, Karen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
401,346 | |
| Filed 2025-09-26 13:52 Tx date 2025-09-25 |
$MDNA
Medicenna Therapeutics Corp. |
Geltosky, John Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
401,346 | |
| Filed 2025-09-26 11:06 Tx date 2025-09-25 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
551,346 | |
| Filed 2025-03-06 18:16 Tx date 2025-03-06 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$31,000
+31,000 vol $1.00 each |
31,000 | |
| Filed 2025-03-06 18:15 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-02-14 15:19 Tx date 2025-02-13 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$645.00
+500 vol $1.29 each |
392,113 | |